Skip to main content
Clinical Trials/2023-508371-36-00
2023-508371-36-00CompletedPhase 1

A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497

Pfizer Inc.1 site in 1 country6 target enrollmentStarted: May 28, 2024Last updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
6
Locations
1

Study Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Clinical Medical Lead

Scientific

Pfizer Inc.

Study Sites (1)

Loading locations...

Similar Trials